Zealand Pharma — November 2023
-
Aggregerede korte nettopositioner er i følge Finanstilsynet faldet til 4.03%.
-
Ser ud til at kæberbe blev vækket igen på 280-285
-
køberne...sorry
-
Godmorgen
-
Dagens mange regnskaber: https://www.proinvestor.com/finanskalender
-
Lilly : FDA Approves Zepbound For Chronic Weight Management, New Option For Treatment Of Obesity https://www.proinvestor.com/investornyt/1076597/lilly-fda-approves-zepbound-for-chronic-weight-management-new-option-for-treatment-of-obesity
-
Godmorgen til en spændende Zeal-dag.
-
ZEAL - Financial Results for the First Nine Mont of 2023 https://www.proinvestor.com/boards/116627
-
"Financial
Solid financial position. * Milestone payments from existing partnerships were recognized in the third quarter of 2023, with cash inflow expected in the fourth quarter of 2023, contributing to the company's solid financial position. These potential milestones include EUR 30 million from Boehringer Ingelheim associated with survodutide and USD 10 million from Sanofi associated with lixisenatide".
-
God morgen og tak for god update
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind